RxDoctor Payments Data

Deidre Johnson, NP

Family · Flowood, MSNPI 1730743329

Payments from drug & device makers

$7,060in general payments, 2019–2025

Across 383 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • AbbVie$1K
  • Pfizer$942
  • Novo Nordisk$829
  • Lilly USA, LLC$452
  • Merck$402
  • plus $2K from 34 others

What the payments were for

  • Travel & lodging$1,39720%
  • Food & beverage$5,66380%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,060 in reported general payments places this provider in the 90th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$158,852
Medicare patients
507
Services billed
3,384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide74$78,845
RybelsusSemaglutide54$60,298
JardianceEmpagliflozin41$52,991
EliquisApixaban51$41,683
XareltoRivaroxaban27$19,541
JanuviaSitagliptin Phosphate17$14,783
MounjaroTirzepatide11$11,518
LinzessLinaclotide21$10,911
TrulicityDulaglutide11$10,409
MyrbetriqMirabegron14$8,129
SynthroidLevothyroxine Sodium58$4,672
Novolog FlexpenInsulin Aspart11$4,189
Rosuvastatin Calcium372$3,632
Potassium Chloride132$2,496
Pravastatin Sodium263$2,459

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$829$139,142128 claims
Boehringer IngelheimJardiance$158$52,99141 claims
PfizerEliquis$942$41,68351 claims
Lilly USA, LLCMounjaro, Trulicity$452$21,92722 claims
Johnson & JohnsonXarelto$14$19,54127 claims
AbbVieLinzess, Synthroid$1,062$15,58379 claims
MerckJanuvia$402$14,78317 claims
Astellas Pharma US IncMyrbetriq$127$8,12914 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$36$2,009265 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,007 family providers in Mississippi.

Other family in Flowood

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →